| Oral probiotics in coronavirus disease 2019: Connecting the gut–lung axis to viral pathogenesis, inflammation, secondary infection and clinical trials P Baindara, R Chakraborty, ZM Holliday, SM Mandal, AG Schrum New microbes and new infections 40, 100837, 2021 | 72 | 2021 |
| Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome AP Earhart, ZM Holliday, HV Hofmann, AG Schrum New microbes and new infections 35, 100689, 2020 | 58 | 2020 |
| Non-randomized trial of dornase alfa for acute respiratory distress syndrome secondary to Covid-19 ZM Holliday, AP Earhart, MM Alnijoumi, A Krvavac, LAH Allen, AG Schrum Frontiers in immunology 12, 714833, 2021 | 39 | 2021 |
| Neutrophils and secondary infections in COVID-19 induced acute respiratory distress syndrome ZM Holliday, MM Alnijoumi, MA Reed, AP Earhart, AG Schrum, LAH Allen, ... New Microbes and New Infections 44, 100944, 2021 | 7 | 2021 |
| Increased incidence, morbidity, and mortality in human coronavirus NL63 associated with ACE inhibitor therapy and implication in SARS-CoV-2 (COVID-19) A Krvavac, TP Patel, EM Karle, NB Epstein, EA Reznikov, LG Gates, ... Missouri Medicine 117 (4), 346, 2020 | 6 | 2020 |
| Invasive pulmonary aspergillosis due to aspergillus niger and COVID-19 pneumonia D Shyu, S Patil, R Wilhite, E Karle, P Beck, M Athey, T Nelson, Z Holliday Tp98. Tp098 Fungus among-Us-Rare Fungal Case Reports, A4011-A4011, 2021 | 3 | 2021 |
| Effects of Tham Nasal Alkalinization on Airway Microbial Communities: A Pilot Study in Non-CF and CF Adults ZM Holliday, JL Launspach, L Durairaj, PK Singh, J Zabner, DA Stoltz Annals of Otology, Rhinology & Laryngology 131 (9), 1013-1020, 2022 | 1 | 2022 |
| Acute salmonella typhimurium aneurysmal aortitis with bacteremia, pneumonia, and thoracic aortic dissection in an elderly male S Patil, M Wieser, C Chen, TB Nelson, Z Holliday, W Roland Cureus 14 (1), 2022 | 1 | 2022 |
| Oral probiotics in COVID-19: connecting the gut-lung axis to viral pathogenesis, inflammation, secondary infection, and clinical trials P Baindara, R Chakraborty, ZM Holliday, SM Mandal, AG Schrum New Microbes New Infect 100837, 2021 | 1 | 2021 |
| Secondary Eosinophilia A risk factor for prolonged hospitalization in severe COVID-19: A case control study M Reed, A Wilden, ZM Holliday Clinical Infection in Practice 20, 100242, 2023 | | 2023 |
| DIAGNOSIS THROUGH OBFUSCATION: NEUROSARCOIDOSIS PRESENTING IN A PATIENT WITH RECENTLY DIAGNOSED PULMONARY SARCOIDOSIS KA Hooshmand, C Baxter, ZM Holliday Chest 162 (4), A2168, 2022 | | 2022 |
| DISSEMINATED PULMONARY HISTOPLASMOSIS PRESENTING AS MILIARY PATTERN ON IMAGING G Gaskey, T Boyd, E Karle, ZM Holliday Chest 162 (4), A460, 2022 | | 2022 |
| 167 Two-year respiratory culture and pulmonary function outcomes in patients on elexacaftor/tezacaftor/ivacaftor Z Holliday Journal of Cystic Fibrosis 21, S98, 2022 | | 2022 |
| Acute Pneumocystis jirovecii Pneumonia Due to Absolute Lymphopenia E Hilker, SM Patil, R Wilhite, Z Holliday Cureus 14 (3), 2022 | | 2022 |
| Streptococcus constellatus Left Ventricular Apical Mural Infective Endocarditis With Acute Stroke, Septic and Cardiogenic Shock E Hilker, SM Patil, Z Holliday, N Arora Cureus 14 (2), 2022 | | 2022 |
| 570: Baseline lung disease before starting elexacaftor/tezacaftor/ivacaftor may predict treatment response Z Holliday Journal of Cystic Fibrosis 20, S270, 2021 | | 2021 |
| COVID-19, COMORBIDITIES, AND OUTCOMES IN SEVERE ILLNESS K Hooshmand, A Wilden, I Zaman, J Dorroh, M Reed, Z Holliday Chest 160 (4), A1110, 2021 | | 2021 |
| IN-HOSPITAL OUTCOMES IN PATIENTS WITH OBESITY AND ACUTE ASTHMA EXACERBATION K Gangu, E Sharma, A Bobba, T Patel, Z Holliday Chest 160 (4), A1831, 2021 | | 2021 |
| Effects of THAM Nasal Alkalinization on Airway Microbial Communities: A Pilot Study ZM Holliday, JL Launspach, L Durairaj, PK Singh, J Zabner, DA Stoltz medRxiv, 2021.02. 14.21251657, 2021 | | 2021 |
| MEDIASTINAL ABSCESS: AN UNCOMMON CAUSE OF DYSPHAGIA M Nance, T Patel, T Gubeladze, Z Holliday Chest 158 (4), A84, 2020 | | 2020 |
